ENTG

Business Context and Reporting Period

Company: Entegris, Inc.
Filing Type: Form 10-Q (Transition Report)
Reporting Period: Four months ended December 31, 2005 (August 28, 2005 – December 31, 2005).
Context: This is a transition report following the Board's approval to change the fiscal year from a 52/53-week period ending in August to a calendar year ending December 31. The period includes the impact of the August 6, 2005 merger with Mykrolis Corporation, accounted for as an acquisition. The Company divested its gas delivery, life science, and tape and reel product lines, classifying them as discontinued operations.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 72% year-over-year, primarily driven by the inclusion of Mykrolis sales ($89.6 million). Currency fluctuations negatively impacted sales by approximately $3.5 million.
• Profitability Decline: Despite revenue growth, the Company reported a net loss of $18.3 million compared to net income of $6.6 million in the prior year. This was driven by:
• Inventory Write-up: A $17.8 million charge to Cost of Sales related to the fair value write-up of inventory acquired in the Mykrolis merger.
• Restructuring Costs: $4.8 million in costs related to manufacturing facility consolidation.
• SG&A Increase: Selling, general, and administrative expenses rose $45.9 million (144%) due to Mykrolis integration costs ($11.3 million), Mykrolis infrastructure ($31.0 million), and increased share-based compensation ($9.6 million).
• Discontinued Operations: Recorded a net loss of $8.0 million, including $6.7 million in impairment charges on assets held for sale.
• Debt Reduction: Total debt decreased significantly as the Company paid off its outstanding long-term debt in Japan and reduced other borrowings.

Guidance, Outlook, and Risks

• Integration Outlook: Management expects to incur total integration expenses of approximately $30 million, with $22 million already recorded. Annualized cost savings of approximately $20 million are expected to be fully realized by mid-2006.
• Capital Expenditures: The Company expects future capital expenditures of $40 million through calendar 2006 for facility expansions and equipment.
• Market Risks:
  • Interest Rates: A 100 basis point change in interest rates could impact annual net income by approximately $1.7 million.
  • Currency: Foreign exchange fluctuations continue to impact results, particularly in Japan.
• Legal Proceedings: The Company is defending a patent infringement suit filed by Pall Corporation (December 2005) and pursuing a suit against Miraial Co. Ltd. regarding wafer container patents.
• Internal Controls: A material weakness in internal controls regarding purchase accounting for compensation matters identified in the prior fiscal year is being remediated. Management concluded disclosure controls were effective as of December 31, 2005, pending full remediation testing.

Investor Verification Checklist

• Inventory Valuation: Verify the $17.8 million inventory write-up charge and its impact on future cost of sales as the acquired inventory turns.
• Integration Synergies: Monitor the realization of the projected $20 million in annualized cost savings and the timing of the remaining $8 million in integration expenses.
• Discontinued Operations: Confirm the final sale price and closing of the gas delivery product line (agreement signed Jan 2006, closed Feb 2006) to assess final gains/losses.
• Share-Based Compensation: Review the impact of SFAS 123(R) adoption, which added $11.1 million in expense for the period, on future earnings.
• Legal Exposure: Track the status of the Pall Corporation patent infringement lawsuit and potential financial impact.